These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23184228)

  • 21. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.
    Ishihara T; Takeda M; Sakamoto H; Kimoto A; Kobayashi C; Takasaki N; Yuki K; Tanaka K; Takenaga M; Igarashi R; Maeda T; Yamakawa N; Okamoto Y; Otsuka M; Ishida T; Kiwada H; Mizushima Y; Mizushima T
    Pharm Res; 2009 Oct; 26(10):2270-9. PubMed ID: 19633820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration.
    Su Y; Liu M; Liang K; Liu X; Song Y; Deng Y
    AAPS PharmSciTech; 2018 Oct; 19(7):3210-3218. PubMed ID: 30187444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.
    Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM
    J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
    Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F; Ye X; Wu Y; Wang H; Sheng C; Peng D; Chen W
    J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
    Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
    Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
    J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
    J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE; Lila ASA; Emam SE; Shimizu T; Takata H; Ando H; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2020 Jul; 152():56-62. PubMed ID: 32376372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38.
    Ebrahimnejad P; Dinarvand R; Jafari MR; Tabasi SA; Atyabi F
    Int J Pharm; 2011 Mar; 406(1-2):122-7. PubMed ID: 21185365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel.
    Ramanlal Chaudhari K; Kumar A; Megraj Khandelwal VK; Ukawala M; Manjappa AS; Mishra AK; Monkkonen J; Ramachandra Murthy RS
    J Control Release; 2012 Mar; 158(3):470-8. PubMed ID: 22146683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.
    Zhao Y; Wang L; Yan M; Ma Y; Zang G; She Z; Deng Y
    Int J Nanomedicine; 2012; 7():2891-900. PubMed ID: 22745552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers.
    Ishihara T; Maeda T; Sakamoto H; Takasaki N; Shigyo M; Ishida T; Kiwada H; Mizushima Y; Mizushima T
    Biomacromolecules; 2010 Oct; 11(10):2700-6. PubMed ID: 20795699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.
    Li C; Zhao X; Wang Y; Yang H; Li H; Li H; Tian W; Yang J; Cui J
    Int J Pharm; 2013 Feb; 443(1-2):17-25. PubMed ID: 23318366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.